{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:43:16Z","timestamp":1767836596425,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.schres.2008.07.005","type":"journal-article","created":{"date-parts":[[2008,8,17]],"date-time":"2008-08-17T09:22:32Z","timestamp":1218964952000},"page":"224-235","source":"Crossref","is-referenced-by-count":57,"title":["Amisulpride the \u2018atypical\u2019 atypical antipsychotic \u2014 Comparison to haloperidol, risperidone and clozapine"],"prefix":"10.1016","volume":"105","author":[{"given":"Sridhar","family":"Natesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg E.","family":"Reckless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karren B.L.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 N.","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitij","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2008.07.005_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"Davis","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","article-title":"Potential role of ABC transporters as a detoxification system at the blood-CSF barrier","volume":"56","author":"de Lange","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.schres.2008.07.005_bib4","first-page":"298","article-title":"Pharmacocinetique et metabolisme de l'amisulpride","volume":"3","author":"Dufour","year":"1988","journal-title":"Ann. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib45","series-title":"Amisulpride","first-page":"43","article-title":"Pharmacokinetics and metabolism of amisulpride","author":"Dufour","year":"1989"},{"key":"10.1016\/j.schres.2008.07.005_bib5","series-title":"Probit Analysis","author":"Finney","year":"1971"},{"key":"10.1016\/j.schres.2008.07.005_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130050165","article-title":"Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice","volume":"129","author":"Gleason","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2008.07.005_bib7","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/sj.npp.1300244","article-title":"How does the benzamide antipsychotic amisulpride get into the brain? \u2014 an in vitro approach comparing amisulpride with clozapine","volume":"28","author":"Hartter","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0091-3057(94)90554-1","article-title":"Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats","volume":"48","author":"Jackson","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2008.07.005_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00018-003-3336-9","article-title":"The ABC transporter structure and mechanism: perspectives on recent research","volume":"61","author":"Jones","year":"2004","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.schres.2008.07.005_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats","volume":"302","author":"Kapur","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2008.07.005_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-3806(90)90163-S","article-title":"A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat","volume":"56","author":"Keep","year":"1990","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"Suppl 1","key":"10.1016\/j.schres.2008.07.005_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S1461145704004109","article-title":"Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials","volume":"7","author":"Leucht","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2008.07.005_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/appi.ajp.159.2.180","article-title":"Amisulpride, an unusual \u201catypical\u201d antipsychotic: a meta-analysis of randomized controlled trials","volume":"159","author":"Leucht","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(02)01602-3","article-title":"Effect of the amisulpride isomers on rat catalepsy","volume":"444","author":"Marchese","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2008.07.005_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(02)01990-8","article-title":"Effect of the amisulpride isomers on rat prolactinemia","volume":"448","author":"Marchese","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2008.07.005_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1185\/030079902125001128","article-title":"A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months","volume":"18","author":"Martin","year":"2002","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2008.07.005_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF00506189","article-title":"Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites","volume":"325","author":"Martres","year":"1984","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.schres.2008.07.005_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(95)00333-G","article-title":"Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors","volume":"280","author":"Maurel-Remy","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2008.07.005_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(99)00046-9","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF00449814","article-title":"Clozapine: new research on efficacy and mechanism of action","volume":"238","author":"Meltzer","year":"1989","journal-title":"Eur. Arch. Psychiatr. Neurol. Sci."},{"key":"10.1016\/j.schres.2008.07.005_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2008.07.005_bib24","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1046\/j.1460-9568.1999.00858.x","article-title":"Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat","volume":"11","author":"Milan","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.schres.2008.07.005_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1300.065","article-title":"Glutamatergic animal models of schizophrenia","volume":"1003","author":"Moghaddam","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.schres.2008.07.005_bib26","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/sj.npp.1300983","article-title":"Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models","volume":"31","author":"Natesan","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib27","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1006\/nimg.2001.0879","article-title":"Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy \u2014 a simulation study based on experimental data","volume":"14","author":"Olsson","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.schres.2008.07.005_bib28","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.schres.2008.07.005_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)36394-3","article-title":"Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity","volume":"280","author":"Perrault","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2008.07.005_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0028-3908(85)90037-1","article-title":"The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration","volume":"24","author":"Protais","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib31","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1073\/pnas.96.7.3900","article-title":"Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier","volume":"96","author":"Rao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2008.07.005_bib32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","article-title":"Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity","volume":"271","author":"Robertson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2008.07.005_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00702-005-0367-4","article-title":"Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp)","volume":"113","author":"Schmitt","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.schres.2008.07.005_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)36395-5","article-title":"Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity","volume":"280","author":"Schoemaker","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2008.07.005_bib35","series-title":"Catecholamines, Part B: Neuropharmacology and Central Nervous System","first-page":"59","article-title":"Biochemical and behavioral identification of discriminant benzamide derivatives: new tools to differentiate sub-classes of dopamine receptors","author":"Schwartz","year":"1984"},{"key":"10.1016\/j.schres.2008.07.005_bib36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0893-133X(02)00375-5","article-title":"Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study","volume":"27","author":"Sechter","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.schres.2008.07.005_bib38","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1176\/appi.ajp.162.10.1984-a","article-title":"An update of fast-off dopamine D2 atypical antipsychotics","volume":"162","author":"Seeman","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.mp.4000336","article-title":"Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors","volume":"3","author":"Seeman","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2008.07.005_bib40","first-page":"224","article-title":"Localization and function of the D3 dopamine receptor","volume":"42","author":"Sokoloff","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.schres.2008.07.005_bib41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00213-005-2161-2","article-title":"Non-uniform blockade of intrastriatal D2\/D3 receptors by risperidone and amisulpride","volume":"180","author":"Stone","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2008.07.005_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","article-title":"Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways","volume":"32","author":"Urban","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.07.005_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002130000466","article-title":"Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats","volume":"150","author":"Wadenberg","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2008.07.005_bib44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.npp.1301181","article-title":"Risperidone and paliperidone inhibit P-glycoprotein activity in vitro","volume":"32","author":"Zhu","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408003277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408003277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:10:32Z","timestamp":1738336232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996408003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":45,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0920996408003277"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2008.07.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}